Our new study is now published in @JCOOP_ASCO. Full text 👉 ascopubs.org/doi/10.1200/OP-… Here’s what we found ⬇️

Honored to be selected as a 2026 ASH Hematology Inclusion Pathway (HIP) Resident Award recipient🩸 Grateful to @ASH_hematology and to my mentors Dr Sophie Lanzkron and Dr Stephanie Guarino for their guidance and support. Excited to continue working on care transitions in sickle cell disease. #ASHAwards #Fight4Hematology

Had a wonderful time at #ASCO26 as a trainee. Thank you @NazliDizman and the @ASCOTECAG team for creating welcoming spaces, mentorship opportunities and trainee-focused programming for residents, fellows and early-career oncologists.

Still reflecting on an inspiring #ASCO26 session for IMG oncologists. “Where you start does not define where you can go” was a powerful message from Dr. @AbiSivaMD and a reminder of the importance of mentorship and community in building a career in oncology as an IMG. #IMGoncCoP @IMG_Oncologists

Great insights from The Oncology Forum GU panel at #ASCO26! Practical discussion translating key GU oncology updates into real-world practice. Thank you @PGrivasMDPhD @CParkMD @katy_beckermann for an excellent session!

Wow 🔥 Fantastic evening at the Advancements in Oncology session by @OncBrothers in #ASCO26! Insightful discussions on the latest advances across lung, GU, breast and GI oncology. Grateful for the opportunity to learn from leaders in the field and connect with the oncology community!

Okay, trainees @ASCO #ASCO26, here is the plan! Badge/bag pickup, then straight to next door: your "home base", the @ASCOTECAG Lounge. Please come say hi! 🔗 Lots of networking starting with @ASCO-SEP trivia at 2.30 pm today! 🤩1:1 mentoring, panels, round table discussions all tailored to the needs of trainees and early career ☕️ Breakfast, snacks and barista coffee 🛋️ Lots of plugs to charge your devices, and comfy couches to recharge yourselves @OncoAlert @montypal @IMG_Oncologists @DrChoueiri @jrgralow @COlazagasti @FionnualaCrowle @ja_ocejo @noha_soror @royaryam @OncoAlert @urotoday @PCF_Science @BladderCancerUS @kidneycan @KidneyCancer @Uromigos @DrKarineTawagi @OncBrothers @crisbergerot @PauloBergerot @realbowtiedoc @DVAraujoMD @DrBarbiOnc @LauraEsfeller @FunchainMD @YGaritaonaindia @jgong15 @DrSAHaddad @GIMedOnc @iandresmeraz @SakditadMD @RamilaShilpakar @RohitBanwar @lungoncdoc

🚨Save the date🚨 @ASCO #IMG Community of Practice Meeting at #ASCO26 ⏰May 29, 1-2:30 PM CST 📌Room E253ab, McCormick Place Join us to discuss barriers & opportunities for #IMGs ASCO IMG CoP👉bit.ly/3JmJQwK @ASCOPost #IMGoncCoP #MedEd #MedTwitter @ASCOTECAG

Honored and grateful to serve as Chief Resident for the 2026-2027 academic year at New York Medical College. Looking forward to learning alongside an incredible group of colleagues while supporting our residents, education, and patient care in the year ahead.

🔎 @CananDirican of @nymedcollege discusses her research evaluating rural disparities in access to #urology and radiation services for patients with localized #prostate cancer, with a focus on distinguishing appropriate active surveillance from potential undertreatment: buff.ly/EOUDjOn

Excited to share a series of interviews on our work examining rural disparities in management of GU cancers. Across disease sites, geography continues to shape access to guideline-concordant care. Grateful to discuss this work with @GUOncologyNow 🔗 Prostate: guoncologynow.com/post/acces…
🔗 Kidney: guoncologynow.com/post/overt…
🔗 Testicular: guoncologynow.com/post/a-dec…

Excited to share our study on rural-urban disparities in early-stage GU cancer management, now published online in @UrolOncol. Using SEER data, we found persistent geographic differences in surgical approach for kidney cancer and receipt of definitive therapy for prostate cancer, despite clear NCCN guidelines. sciencedirect.com/science/ar… #MedTwitter #Oncology #UroOnc #HealthEquity

Grateful to contribute to projects presented at #NCCN2026 alongside colleagues, spanning outcomes research and immunotherapy. Really value the opportunity to collaborate across different areas of oncology and to learn from this team.

Excited to present our work on rural disparities in the management of cT1a renal masses at #NCCN2026 Among surgically managed patients, guideline-concordant nephron-sparing care remains unevenly accessible. Grateful for the mentorship and collaboration that made this possible. #MedTwitter #HemeOnc #UroOnc #HealthDisparities

Thank you @IMG_Oncologists for highlighting our project! @ASCO #GU26

Challenge of Underrepresentation of Black and Hispanic Men in Advanced Prostate Cancer Trials—Progress? Read the full article. brnw.ch/21wZgDf

Richter’s transformation remains a major unmet need. We summarized available clinical evidence on BTK inhibitors (efficacy safety) in a systematic review, now published in Frontiers in Oncology. doi.org/10.3389/fonc.2025.16… #RichtersTransformation #CLL